Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study.

Ito, Hiroyuki; Araki, Rie; Mori, Toshiko; Inoue, Hideyuki; Matsumoto, Suzuko; Antoku, Shinichi; Yamasaki, Tomoko; Togane, Michiko

Ito, Hiroyuki; Araki, Rie; Mori, Toshiko; Inoue, Hideyuki; Matsumoto, Suzuko; Antoku, Shinichi; Yamasaki, Tomoko; Togane, Michiko.

Afiliación

Ito H; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Araki R; Nephrology, Edogawa Hospital, Tokyo, JPN.
Mori T; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Inoue H; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Matsumoto S; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Antoku S; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Yamasaki T; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.
Togane M; Diabetes and Endocrinology, Edogawa Hospital, Tokyo, JPN.

Cureus ; 15(5): e39543, 2023 May.

Article en En | MEDLINE | ID: mdl-37378104

Palabras clave

chronic kidney disease; diabetes; hypoxia-inducible factor prolyl hydroxylase inhibitor; renal anemia; roxadustat

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article